Related Experiment Video
Updated: Jul 9, 2026
Collection of Alfalfa Root Exudates to Study the Impact of Di(2-ethylhexyl) Phthalate on Metabolite Production
Published on: June 2, 2023
Simulated neonatal exposure to DEHP and MEHP from PVC enteral nutrition products
Satoshi Takatori1, You Okamoto, Yoko Kitagawa
1Division of Food Chemistry, Osaka Prefectural Institute of Public Health, 1-3-69 Nakamichi, Higashinari-ku, Osaka 537-0025, Japan. sts-tkt@iph.pref.osaka.jp
Insights
Di(2-ethylhexyl)phthalate (DEHP) leaches from polyvinyl-chloride (PVC) medical devices into neonatal enteral nutrition (EN). Using DEHP-free products significantly reduces infant exposure to DEHP and its metabolite MEHP.
Area of Science:
- Neonatal medicine
- Environmental health
- Materials science
Background:
- Neonatal patients often receive enteral nutrition (EN) via medical devices.
- Polyvinyl-chloride (PVC) medical products frequently contain di(2-ethylhexyl)phthalate (DEHP) as a plasticizer.
- Concerns exist regarding the leaching of DEHP and its metabolite mono(2-ethylhexyl)phthalate (MEHP) into EN.
Purpose of the Study:
- To quantify DEHP and MEHP leaching from PVC medical products into EN under simulated neonatal conditions.
- To assess the potential daily exposure of neonatal patients to DEHP and MEHP.
- To evaluate the effectiveness of DEHP-free medical products in reducing exposure.
Main Methods:
- A simulated study mimicking EN administration to a 3 kg neonatal patient at 25°C.
- Analysis of DEHP and MEHP levels leaching from PVC irrigators and catheters (9.1-31.8% DEHP w/w) into EN.
- Calculation of worst-case daily exposure estimates for DEHP and MEHP.
Main Results:
- Estimated worst-case daily exposures to DEHP and MEHP were 148 and 3.72 µg/(kg day), respectively.
- Leaching significantly increased DEHP and MEHP levels in EN compared to preparation levels.
- The use of DEHP-free medical products reduced exposure to baseline levels present in the EN itself.
Conclusions:
- Medical products containing DEHP can leach significant amounts of DEHP and MEHP into neonatal enteral nutrition.
- Transitioning to DEHP-free medical products is an effective strategy to minimize neonatal exposure to these compounds via EN.
- Reducing DEHP exposure in neonatal care is crucial for patient safety.
Abstract:
The leaching of di(2-ethylhexyl)phthalate (DEHP) and mono(2-ethylhexyl)phthalate (MEHP) from medical products made of polyvinyl-chloride (PVC) to enteral nutrition (EN) for neonatal patients was determined in a simulated study. The study simulated a typical case of EN administration to a neonatal patient (body weight, 3 kg) in a neonatal care unit (temperature, 25 degrees C); the medical products used were an irrigator and catheter containing DEHP (9.1-31.8%, w/w) as a plasticizer. The worst-case daily exposures of the neonatal patient to DEHP and MEHP by the administration of EN were estimated to be 148 and 3.72 microg/(kg day), respectively, as assessed from the levels of these compounds leaching from the medical products to the EN. The use of DEHP-free medical products reduced the exposure of DEHP and MEHP to the minimum levels contained in the EN at preparation. A transition to DEHP-free medical products for neonatal patients would be effective in reducing the exposure of neonatal patients to DEHP via EN administration.
More Related Videos
08:28Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays
Published on: April 26, 2018
09:13A Neonatal Mouse Model of Necrotizing Enterocolitis and Lamina Propria Isolation for Immune Cell Profiling
Published on: September 19, 2025
